154 related articles for article (PubMed ID: 11316852)
21. Effect of a specific endothelin receptor A antagonist and an angiotensin-converting enzyme inhibitor on glomerular mRNA levels for extracellular matrix components, metalloproteinases (MMP) and a tissue inhibitor of MMP in aminonucleoside nephrosis.
Ebihara I; Nakamura T; Tomino Y; Koide H
Nephrol Dial Transplant; 1997 May; 12(5):1001-6. PubMed ID: 9175058
[TBL] [Abstract][Full Text] [Related]
22. Passive Heymann nephritis: evidence that angiotensin-converting enzyme inhibition reduces proteinuria and retards renal structural injury.
Zoja C; Corna D; Bruzzi I; Foglieni C; Bertani T; Remuzzi G; Benigni A
Exp Nephrol; 1996; 4(4):213-21. PubMed ID: 8983642
[TBL] [Abstract][Full Text] [Related]
23. Expression of the slit-diaphragm protein, nephrin, in experimental diabetic nephropathy: differing effects of anti-proteinuric therapies.
Kelly DJ; Aaltonen P; Cox AJ; Rumble JR; Langham R; Panagiotopoulos S; Jerums G; Holthöfer H; Gilbert RE
Nephrol Dial Transplant; 2002 Jul; 17(7):1327-32. PubMed ID: 12105259
[TBL] [Abstract][Full Text] [Related]
24. Regulation of glomerular heparanase expression by aldosterone, angiotensin II and reactive oxygen species.
van den Hoven MJ; Waanders F; Rops AL; Kramer AB; van Goor H; Berden JH; Navis G; van der Vlag J
Nephrol Dial Transplant; 2009 Sep; 24(9):2637-45. PubMed ID: 19429930
[TBL] [Abstract][Full Text] [Related]
25. Effect of angiotensin II antagonism on the regression of kidney disease in the rat.
Remuzzi A; Gagliardini E; Donadoni C; Fassi A; Sangalli F; Lepre MS; Remuzzi G; Benigni A
Kidney Int; 2002 Sep; 62(3):885-94. PubMed ID: 12164870
[TBL] [Abstract][Full Text] [Related]
26. Glomerular abundance of nephrin and podocin in experimental nephrotic syndrome: different effects of antiproteinuric therapies.
Nakhoul F; Ramadan R; Khankin E; Yaccob A; Kositch Z; Lewin M; Assady S; Abassi Z
Am J Physiol Renal Physiol; 2005 Oct; 289(4):F880-90. PubMed ID: 15942045
[TBL] [Abstract][Full Text] [Related]
27. Effect of angiotensin II type 1 receptor blocker on 12-lipoxygenase activity and slit diaphragm protein expression in type 2 diabetic rat glomeruli.
Xu HZ; Wang WN; Zhang YY; Cheng YL; Xu ZG
J Nephrol; 2016 Dec; 29(6):775-782. PubMed ID: 27021232
[TBL] [Abstract][Full Text] [Related]
28. Comparable effects of angiotensin II and converting enzyme blockade on hemodynamics and cardiac hypertrophy in spontaneously hypertensive rats.
Mori T; Nishimura H; Ueyama M; Kubota J; Kawamura K
Jpn Circ J; 1995 Sep; 59(9):624-30. PubMed ID: 7500546
[TBL] [Abstract][Full Text] [Related]
29. Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2.
Ferrario CM; Jessup J; Chappell MC; Averill DB; Brosnihan KB; Tallant EA; Diz DI; Gallagher PE
Circulation; 2005 May; 111(20):2605-10. PubMed ID: 15897343
[TBL] [Abstract][Full Text] [Related]
30. Role of nephrin phosphorylation inducted by dexamethasone and angiotensin II in podocytes.
Yu M; Ren Q; Yu SY
Mol Biol Rep; 2014 Jun; 41(6):3591-5. PubMed ID: 24515388
[TBL] [Abstract][Full Text] [Related]
31. Angiotensin II receptor blocker inhibits p27Kip1 expression in glucose-stimulated podocytes and in diabetic glomeruli.
Xu ZG; Yoo TH; Ryu DR; Cheon Park H; Ha SK; Han DS; Adler SG; Natarajan R; Kang SW
Kidney Int; 2005 Mar; 67(3):944-52. PubMed ID: 15698433
[TBL] [Abstract][Full Text] [Related]
32. Regulation of the renal angiotensin II receptor gene in acute unilateral ureteral obstruction.
Pimentel JL; Wang S; Martinez-Maldonado M
Kidney Int; 1994 Jun; 45(6):1614-21. PubMed ID: 7933808
[TBL] [Abstract][Full Text] [Related]
33. Chronic angiotensin II infusion but not bradykinin blockade abolishes the antiproteinuric response to angiotensin-converting enzyme inhibition in established adriamycin nephrosis.
Wapstra FH; Navis G; DE Jong PE; DE Zeeuw D
J Am Soc Nephrol; 2000 Mar; 11(3):490-496. PubMed ID: 10703672
[TBL] [Abstract][Full Text] [Related]
34. Modulation of plasminogen activator inhibitor-1 in vivo: a new mechanism for the anti-fibrotic effect of renin-angiotensin inhibition.
Oikawa T; Freeman M; Lo W; Vaughan DE; Fogo A
Kidney Int; 1997 Jan; 51(1):164-72. PubMed ID: 8995730
[TBL] [Abstract][Full Text] [Related]
35. Snail, a transcriptional regulator, represses nephrin expression in glomerular epithelial cells of nephrotic rats.
Matsui I; Ito T; Kurihara H; Imai E; Ogihara T; Hori M
Lab Invest; 2007 Mar; 87(3):273-83. PubMed ID: 17260001
[TBL] [Abstract][Full Text] [Related]
36. Adding a statin to a combination of ACE inhibitor and ARB normalizes proteinuria in experimental diabetes, which translates into full renoprotection.
Zoja C; Corna D; Gagliardini E; Conti S; Arnaboldi L; Benigni A; Remuzzi G
Am J Physiol Renal Physiol; 2010 Nov; 299(5):F1203-11. PubMed ID: 20719975
[TBL] [Abstract][Full Text] [Related]
37. Prevention of angiotensin II induced myocyte necrosis and coronary vascular damage by lisinopril and losartan in the rat.
Kabour A; Henegar JR; Devineni VR; Janicki JS
Cardiovasc Res; 1995 Apr; 29(4):543-8. PubMed ID: 7796449
[TBL] [Abstract][Full Text] [Related]
38. Expression of nephrin in acquired human glomerular disease.
Huh W; Kim DJ; Kim MK; Kim YG; Oh HY; Ruotsalainen V; Tryggvason K
Nephrol Dial Transplant; 2002 Mar; 17(3):478-84. PubMed ID: 11865096
[TBL] [Abstract][Full Text] [Related]
39. Blocking angiotensin II ameliorates proteinuria and glomerular lesions in progressive mesangioproliferative glomerulonephritis.
Nakamura T; Obata J; Kimura H; Ohno S; Yoshida Y; Kawachi H; Shimizu F
Kidney Int; 1999 Mar; 55(3):877-89. PubMed ID: 10027924
[TBL] [Abstract][Full Text] [Related]
40. Angiotensin II type I receptor antagonist suppresses proteinuria and glomerular lesions in experimental nephritis.
Nagamatsu T; Hayashi K; Oka T; Suzuki Y
Eur J Pharmacol; 1999 Jun; 374(1):93-101. PubMed ID: 10422645
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]